OFI Advisors’s Idexx Laboratories IDXX Stock Holding History

OFI Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$261K	Sell	3,515 -2,433	-41%	-$174K	0.02%	1073
2015 Q2	$382K	Buy	5,948 +2,420	+69%	+$168K	0.02%	912
2015 Q1	$273K	Sell	3,528 -100	-3%	-$7.78K	0.02%	1077
2014 Q4	$269K	Sell	3,628 -450	-11%	-$31.6K	0.02%	1050
2014 Q3	$240K	Buy	4,078 +418	+11%	+$26.4K	0.02%	1042
2014 Q2	$244K	Buy	3,660 +364	+11%	+$23.1K	0.02%	1053
2014 Q1	$200K	Sell	3,296 -116	-3%	-$6.91K	0.02%	1108
2013 Q4	$181K	Buy	3,412 +380	+13%	+$20K	0.01%	1135
2013 Q3	$151K	Sell	3,032 -116	-4%	-$5.58K	0.01%	1133
2013 Q2	$141K	Buy	+3,148	New	+$138K	0.01%	1082

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OFI Advisors's IDXX Position: Q3 2015 in Review

OFI Advisors reduced its Idexx Laboratories (IDXX) stake by 41% in Q3 2015, selling an estimated $174K and leaving 3,515 shares worth $261K. The position accounts for 0.02% of the portfolio, ranked #1073.

OFI Advisors first reported a position in IDXX in Q2 2013 and has held it in 10 quarters since. The position peaked at $382K in Q2 2015. 356 funds tracked by Wall St. Rank hold IDXX as of Q3 2015.

OFI Advisors held 3,515 shares of Idexx Laboratories worth $261K as of Q3 2015.
OFI Advisors sold 2,433 Idexx Laboratories shares in Q3 2015, an estimated $174K.
Idexx Laboratories made up 0.02% of OFI Advisors's portfolio in Q3 2015, its #1073 holding.
OFI Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Idexx Laboratories position peaked at $382K in Q2 2015.
356 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.